Literature DB >> 996727

Positional vertigo with cerebellar astrocytoma.

F K Gregorius, P H Crandall, R W Baloh.   

Abstract

The authors present two surgically verified cases of cerebellar astrocytoma extending into the fourth ventricular floor. Each patient presented with positional vertigo, and electronystagmography revealed positional nystagmus indicative of a central lesion. The findings in these cases emphasize the need of looking for positional nystagmus in patients with suspected posterior fossa lesions.

Entities:  

Mesh:

Year:  1976        PMID: 996727

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

Review 1.  Modern vestibular function testing.

Authors:  R W Baloh; J M Furman
Journal:  West J Med       Date:  1989-01

2.  Positional nystagmus and vertigo due to a solitary brachium conjunctivum plaque.

Authors:  E Anagnostou; D Mandellos; G Limbitaki; A Papadimitriou; D Anastasopoulos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

3.  Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.

Authors:  Christoph Helmchen; Stefan Gottschalk; Thurid Sander; Peter Trillenberg; Holger Rambold; Andreas Sprenger
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

4.  Cerebellar astrocytoma presenting as deterioration of handwriting in a child.

Authors:  S Harel; M Holtzman; U Jurgenson; I Reider; M Feinsod
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

5.  Cerebellar degeneration associated with Sjögren's syndrome.

Authors:  Mi Jung Kim; Myoung Chong Lee; Jae-Hong Lee; Sun Ju Chung
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

6.  Intracranial tumors mimicking benign paroxysmal positional vertigo: A case series.

Authors:  Yuan Xing Chen; Han Jun Sun; Xue Tao Mu; Chao Jiang; Hui Bing Wang; Qing Hua Zhang; Yuan Yi Qu; Jian Li; Ling Ling Zhou; Long Zhu Zhao; Ning Yu; Qing Sun
Journal:  Front Neurol       Date:  2022-09-23       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.